Stage IIIB Breast Cancer AJCC v7 Recruiting Phase 1 Trials for Cetuximab (DB00002)

IndicationStatusPhase
DBCOND0092287 (Stage IIIB Breast Cancer AJCC v7)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01552434Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign DiseaseTreatment